64B16-28.850: Special Pharmacy - ESRD
PURPOSE AND EFFECT: The Board proposes the rule amendment to add additional drugs to the rule.
SUBJECT AREA TO BE ADDRESSED: Special Pharmacy-ESRD.
SPECIFIC AUTHORITY: 465.005, 465.0125 FS.
LAW IMPLEMENTED: 465.0196, 465.022 FS.
IF REQUESTED IN WRITING AND NOT DEEMED UNNECESSARY BY THE AGENCY HEAD, A RULE DEVELOPMENT WORKSHOP WILL BE NOTICED IN THE NEXT AVAILABLE FLORIDA ADMINISTRATIVE WEEKLY.
THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE DEVELOPMENT AND A COPY OF THE PRELIMINARY DRAFT, IF AVAILABLE, IS: Rebecca Poston, Executive Director, Board of Pharmacy/MQA, 4052 Bald Cypress Way, Bin C04, Tallahassee, Florida 32399-3254
THE PRELIMINARY TEXT OF THE PROPOSED RULE DEVELOPMENT IS:
64B16-28.850 Special Pharmacy ESRD.
(1) through (2) No change.
(3) Schedule of legend drugs:
(a) Saline Solutions.
(b) Porcine Heparin.
(c) Beef Heparin.
(d) Dextrose Solutions.
(e) Doxercalciferol.
(f) Epoetin Alfa.
(g)(e) NACL INJ 50 MEQ/20 ML.
(h) Levocarnitine.
(i)(f) Lidocaine.
(j)(g) Vitamin Preparations (dialysate use only).
(k) Paricalcitrol.
(l)(h) Peritoneal Dialysate Solutions.
(m)(i) Protamine Sulfate.
(n)(j) Potassium 20 MEQ/10ML (dialysate use only).
(o) Sodium Ferric Gluconate Complex or equivalent.
(p)(k) Sterile Water for Irrigation.
(4) through (17) No change.
Specific Authority 465.005, 465.0125 FS. Law Implemented 465.0196, 465.022 FS. HistoryNew 10-2-94, Formerly 59X-28.850, Amended 9-20-99, 7-17-05,________.
